ArticleBMB reports2020

Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.

Da-Hyun Kim et al.PubMed ↗Full text ↗

No numbers read from the abstract.